Related Experiment Video
Updated: Aug 31, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.5K
Deep learning-based 4D-synthetic CTs from sparse-view CBCTs for dose calculations in adaptive proton therapy
Adrian Thummerer1, Carmen Seller Oria1, Paolo Zaffino2
1Department, of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Medical Physics
|August 19, 2022
Summary
Deep learning generates synthetic CTs (sCTs) from 4D-CBCT for accurate proton therapy dose calculations. This approach shows promising results for adaptive lung cancer treatment, though lung tissue CT number accuracy needs improvement.
Area of Science:
- Medical Imaging
- Radiotherapy Physics
- Artificial Intelligence in Medicine
Background:
- Time-resolved 4D cone beam-computed tomography (4D-CBCT) enables daily anatomical and motion assessment but suffers from artifacts impacting CT number accuracy for proton dose calculations.
- Deep learning offers a solution by correcting CT numbers and generating synthetic CTs (sCTs) to facilitate CBCT-based proton dose calculations.
Purpose of the Study:
- To convert sparse view 4D-CBCTs into 4D-sCTs using a deep convolutional neural network (DCNN).
- To evaluate the image quality and dosimetric accuracy of 4D-sCTs for feasible proton dose calculations in adaptive proton therapy for lung cancer.
Main Methods:
- A DCNN was trained and evaluated on 45 thoracic cancer patients' data, using sparse view 4D-CBCTs reconstructed from 3D acquisition protocols.
- Image quality was assessed using Mean Absolute Error (MAE) and mean error against daily 4D-CTs.
- Dosimetric accuracy was evaluated globally (gamma analysis) and locally for target volumes and organs-at-risk (OARs), including range error simulations and 4D dose reconstruction.
Main Results:
- 4D-sCTs achieved average MAEs of 48.1 ± 6.5 HU (single phase) and 37.7 ± 6.2 HU (average).
- Global dosimetric evaluation showed gamma pass ratios of 92.3% ± 3.2% (single phase) and 94.4% ± 2.1% (average).
- Clinical target volume dose agreement was high (D98 differences < 2.4%), while OAR mean dose differences were up to 8.4%; lung tissues showed higher range errors.
Conclusions:
- Deep learning-based 4D-sCTs demonstrate accuracy for daily dose calculations in adaptive proton therapy.
- Comparable global and local dosimetric accuracy was achieved despite image quality differences between 4D-sCTs and 3D-sCTs.
- Improving CT number accuracy in lung tissues is crucial for further enhancement of 4D lung sCTs.

